menu
    • menu

    Company profile for Tisento Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Tisento Therapeutics believes in initiating meaningful innovation through a profound understanding of problems, starting with active listening. The company prioritizes listening to individuals affected by debilitating diseases, aiming to grasp their daily challenges. Tisento engages with patients, healthcare providers, advocates, regulatory agencies, and scientific data to inform research, trial design, and company evolution. ...
    Tisento Therapeutics believes in initiating meaningful innovation through a profound understanding of problems, starting with active listening. The company prioritizes listening to individuals affected by debilitating diseases, aiming to grasp their daily challenges. Tisento engages with patients, healthcare providers, advocates, regulatory agencies, and scientific data to inform research, trial design, and company evolution. This inclusive approach emphasizes the commitment to developing solutions that are scientifically robust and aligned with real-world needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Tisento TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, Riverview II, 18th Floor Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tisentotx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tisentotx/?trk=organization_guest_main-feed-card-text
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/tisentotx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    First PRIZM Participant Enrolled in Tisento's MELAS Study
    First PRIZM Participant Enrolled in Tisento's MELAS Study

    20 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/20/3136285/0/en/First-PRIZM-Study-Participant-Enrolled-in-Tisento-Therapeutics-Open-Label-Extension-Study-in-MELAS.html

    GLOBENEWSWIRE
    20 Aug 2025
    Share Share
    Tisento Therapeutics Gets FDA Fast Track for Zagociguat for MELAS
    Tisento Therapeutics Gets FDA Fast Track for Zagociguat for MELAS

    17 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/17/3100526/0/en/Tisento-Therapeutics-Receives-U-S-FDA-Fast-Track-Designation-for-Zagociguat-for-the-Treatment-of-MELAS.html

    GLOBENEWSWIRE
    17 Jun 2025
    Share Share
    Tisento Showcases Mitochondrial Drug Progress at Two Key Events
    Tisento Showcases Mitochondrial Drug Progress at Two Key Events

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3080986/0/en/Tisento-Highlights-Two-Venues-Advancing-Patient-Focused-Therapeutic-Development-for-Mitochondrial-Diseases.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share
    Tisento Doses First Patient In Zagociguat Phase 2b PRIZM Study
    Tisento Doses First Patient In Zagociguat Phase 2b PRIZM Study

    27 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/27/3015457/0/en/First-Participant-Dosed-in-Tisento-Therapeutics-Global-Phase-2b-PRIZM-Study-Evaluating-Zagociguat-for-the-Treatment-of-MELAS.html

    GLOBENEWSWIRE
    27 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search